Home >
Medicine Info >
Dermanex 0.1% Ointment
Loading interface...

Dermanex 0.1% Ointment

Manufactured byTorrent Pharmaceuticals Ltd.
ContainsMometasone
Description
Dermanex 0.1% Ointment is a topical medicine used to treat skin conditions such as psoriasis (a condition in which skin cells build up and cause dry, itchy, and scaly patches), eczema (a skin condition in which skin becomes dry, itchy, red, and bumpy), and dermatitis (skin irritation). This medicine works by decreasing the production of certain chemicals in your body. Thus, it reduces redness, itching, and swelling of your skin. Dermanex 0.1% Ointment may cause side effects like burning sensation, irritation, itching, and redness at the site of application. However, these side effects are temporary and resolve with time. Before you start using this ointment, perform a patch test by applying it to a small area on your skin to know how your skin will react to Dermanex 0.1% Ointment. Discontinue the use if you experience excessive itching or swelling. Dermanex 0.1% Ointment is recommended for external use only. Clean the affected area and pat dry before applying Dermanex 0.1% Ointment. Apply a thin layer of this ointment to the affected area and spread evenly. Avoid direct contact with your eyes and mouth. Wash your eyes and mouth immediately in case of accidental contact. To get maximum benefits, use it regularly as advised by your doctor. If you do not notice any improvement in your skin condition, consult your doctor for further guidance. Dermanex 0.1% Ointment should be avoided if you are allergic to it. Inform your doctor if you have any other skin conditions or using any other topical medicines. Consult your doctor if you are pregnant, or are breastfeeding before using this medicine.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Dermanex 0.1% Ointment

Momate 0.1% Ointment
Glenmark Pharmaceuticals Ltd.
Momesone 0.1% Ointment
Intas Pharmaceuticals Ltd.
Momstar 0.1% Ointment
Mankind Pharmaceuticals Ltd.
Topcort 0.1% Ointment
Cipla Ltd.

Side effects

Major & minor side effects for Dermanex 0.1% Ointment

  • Burning sensation
  • Skin irritation

Uses of Dermanex 0.1% Ointment

What is it prescribed for?

  • Steroid responsive skin conditions
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for Dermanex 0.1% Ointment to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which Dermanex 0.1% Ointment remains active in your body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Dermanex 0.1% Ointment.
  • Can this medicine be taken during pregnancy?
    Dermanex 0.1% Ointment is not recommended for use during pregnancy. Hence, consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Dermanex 0.1% Ointment may be used with caution while breastfeeding. However, topical application to the nipple area may increase the risk of side effects in your baby. Avoid breastfeeding if you have applied this medicine around the nipples.

Allergy

Avoid using Dermanex 0.1% Ointment if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Dermanex 0.1% Ointment is not recommended for use during pregnancy. Hence, consult your doctor if you are pregnant.

Breast-feeding

Dermanex 0.1% Ointment may be used with caution while breastfeeding. However, topical application to the nipple area may increase the risk of side effects in your baby. Avoid breastfeeding if you have applied this medicine around the nipples.
General warnings

External use only

Dermanex 0.1% Ointment is recommended for external use only. Avoid contact with the eyes, mouth, and open wounds.

Use in children

Dermanex 0.1% Ointment is not recommended for use in children less than 2 years of age as the safety and efficacy data are not clinically established.

Other medicines

Dermanex 0.1% Ointment may interact with many other medicines and cause undesired effects. Hence, inform your doctor if you are using any other topical medicines before beginning treatment with Dermanex 0.1% Ointment.

Missed Dose

Apply the missed dose of Dermanex 0.1% Ointment as soon as you remember. If it is time for your next dose, skip the missed dose. Do not apply a double dose to make up for the missed dose.

Overdose

An overdose of Dermanex 0.1% Ointment is not likely to cause severe symptoms unless it is applied for a prolonged period in large amounts. However, ingestion of this medicine may cause harm and immediate medical intervention may be required.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Hyperadrenocorticism

Hyperadrenocorticism is a condition that occurs due to high levels of cortisol (a chemical substance that helps your body respond to stress, regulate blood sugar, and fight infections) in the body. Dermanex 0.1% Ointment should be used with caution as it may occasionally cause or worsen hyperadrenocorticism if applied over a large area for a prolonged time.

Ocular Toxicities

Rarely, Dermanex 0.1% Ointment may increase the intraocular pressure (high pressure inside the eye caused by an imbalance in the production and drainage of fluid in the eye) and cause glaucoma (a condition where the pressure within the eyeballs is abnormally high that can damage the optic nerve and lead to loss of vision). Inform your doctor if you experience any vision problems.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Apply a thin layer of Dermanex 0.1% Ointment to the affected areas of the skin as instructed by your doctor. Follow all the usage instructions mentioned on the label or the package insert. Do not apply in larger or smaller quantities than recommended. Avoid covering the application area with bandages or other dressings unless specifically instructed by your doctor. Contact your doctor if your symptoms do not improve or resolve within 2-4 weeks. Avoid using Dermanex 0.1% Ointment for more than the prescribed duration.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Dermanex 0.1% Ointment inhibits the production of certain chemicals in your body and reduces swelling, itching, and redness of your skin.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Topical steroids

Schedule

Schedule H

Drugs, H., 2021. Mometasone Topical: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 29 October 2021].

https://medlineplus.gov/druginfo/meds/a687014.html>

Medicines.org.uk. 2021. Elocon Ointment - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 29 October 2021].

https://www.medicines.org.uk/emc/product/79/smpc>

Dailymed.nlm.nih.gov. 2021. DailyMed - MOMETASONE FUROATE- mometasone furoate ointment. [online] Available at: < [Accessed 29 October 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5b30e5e-b067-e28c-b7c5-aa58f4c57f09>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 29 October 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019543s024lbl.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 29 Oct 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.